Abstract
The OPRD1 gene encodes the delta-opioid receptor, which has multiple functions including regulating reward pathways. The gene contains more than 2,000 verified genetic variants but only 2 currently have evidence for specific functions: rs1042114 disrupts maturation of the receptor and rs569356 affects OPRD1 expression. These polymorphisms and others in the gene have been found to be associated with human diseases. The most reproducible data are associations between opioid addiction and three variants in intron 1 (rs2236861, rs2236857, and rs3766951), which have been described in a number of independent populations. Several publications also point toward an association between anorexia and a haplotype block containing rs569356 and rs533123. Unfortunately the mechanisms underlying these two effects are currently unknown. In contrast, rs1042114 has been linked to Alzheimer’s disease through an increasingly well-defined mechanism by which the variant allele reduces production of the beta-amyloid plaques associated with the disease. Additional studies of OPRD1 variants are necessary to replicate current findings and to delineate the functional roles of relevant polymorphisms.
References
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer’s disease. Lancet 377(9770):1019–1031
Beer B, Erb R, Pavlic M, Ulmer H, Giacomuzzi S, Riemer Y et al (2013) Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. PLoS One 8(9):e75359
Bergen AW, van den Bree MB, Yeager M, Welch R, Ganjei JK, Haque K et al (2003) Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa. Mol Psychiatry 8(4):397–406
Boraska V, Davis OS, Cherkas LF, Helder SG, Harris J, Krug I et al (2012) Genome-wide association analysis of eating disorder-related symptoms, behaviors, and personality traits. Am J Med Genet B Neuropsychiatr Genet 159B(7):803–811
Boraska V, Franklin CS, Floyd JA, Thornton LM, Huckins LM, Southam L et al (2014) A genome-wide association study of anorexia nervosa. Mol Psychiatry 19(10):1085–1094
Brown KM, Bujac SR, Mann ET, Campbell DA, Stubbins MJ, Blundell JE (2007) Further evidence of association of OPRD1 & HTR1D polymorphisms with susceptibility to anorexia nervosa. Biol Psychiatry 61(3):367–373
Clarke TK, Crist RC, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ et al (2014) Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. Pharmacogenomics J 14(3):303–308
Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C et al (2013a) Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug Alcohol Depend 127(1–3):122–128
Crist RC, Clarke TK, Ang A, Ambrose-Lanci LM, Lohoff FW, Saxon AJ et al (2013b) An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology 38(10):2003–2010
Edenberg HJ (2011) Common and rare variants in alcohol dependence. Biol Psychiatry 70(6):498–499
Franke P, Nothen MM, Wang T, Neidt H, Knapp M, Lichtermann D et al (1999) Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 88(5):462–464
Grice DE, Halmi KA, Fichter MM, Strober M, Woodside DB, Treasure JT et al (2002) Evidence for a susceptibility gene for anorexia nervosa on chromosome 1. Am J Hum Genet 70(3):787–792
Hadjiconstantinou M, Neff NH (2011) Nicotine and endogenous opioids: neurochemical and pharmacological evidence. Neuropharmacology 60(7–8):1209–1220
Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) 129(2):99–111
Janecka A, Fichna J, Janecki T (2004) Opioid receptors and their ligands. Curr Top Med Chem 4(1):1–17
Kaye WH, Lilenfeld LR, Berrettini WH, Strober M, Devlin B, Klump KL et al (2000) A search for susceptibility loci for anorexia nervosa: methods and sample description. Biol Psychiatry 47(9):794–803
Kendler KS, Jacobson KC, Prescott CA, Neale MC (2003) Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160(4):687–695
Kvaloy K, Kulle B, Romundstad P, Holmen TL (2013) Sex-specific effects of weight-affecting gene variants in a life course perspective – the HUNT study, Norway. Int J Obes (Lond) 37(9):1221–1229
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45(12):1452–1458
Leskela TT, Markkanen PM, Alahuhta IA, Tuusa JT, Petaja-Repo UE (2009) Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor. Traffic 10(1):116–129
Leskela TT, Lackman JJ, Vierimaa MM, Kobayashi H, Bouvier M, Petaja-Repo UE (2012) Cys-27 variant of human delta-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization. J Biol Chem 287(7):5008–5020
Levran O, Londono D, O’Hara K, Nielsen DA, Peles E, Rotrosen J et al (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7(7):720–729
Li Z, Zhang H (2013) Analyzing interaction of mu-, delta- and kappa-opioid receptor gene variants on alcohol or drug dependence using a pattern discovery-based method. J Addict Res Ther Suppl 7:007
Loh el W, Fann CS, Chang YT, Chang CJ, Cheng AT (2004) Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res 28(1):15–19
Maddalena A, Papassotiropoulos A, Muller-Tillmanns B, Jung HH, Hegi T, Nitsch RM et al (2003) Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Arch Neurol 60(9):1202–1206
Maher BS, Vladimirov VI, Latendresse SJ, Thiselton DL, McNamee R, Kang M et al (2011) The AVPR1A gene and substance use disorders: association, replication, and functional evidence. Biol Psychiatry 70(6):519–527
Mathes WF, Brownley KA, Mo X, Bulik CM (2009) The biology of binge eating. Appetite 52(3):545–553
Mathieu-Kia AM, Fan LQ, Kreek MJ, Simon EJ, Hiller JM (2001) Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients. Brain Res 893(1–2):121–134
Mayer P, Rochlitz H, Rauch E, Rommelspacher H, Hasse HE, Schmidt S et al (1997) Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 8(11):2547–2550
Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B et al (1998) Familial transmission of substance use disorders. Arch Gen Psychiatry 55(11):973–979
Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL et al (2012) Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addict Biol 19:111–121
Ripke S (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421–427
Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M et al (2014) A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations. Hum Brain Mapp 35(4):1226–1236
Sala L, Mirabel-Sarron C, Pham-Scottez A, Blanchet A, Rouillon F, Gorwood P (2012) Body dissatisfaction is improved but the ideal silhouette is unchanged during weight recovery in anorexia nervosa female inpatients. Eat Weight Disord 17(2):e109–e115
Sarajarvi T, Tuusa JT, Haapasalo A, Lackman JJ, Sormunen R, Helisalmi S et al (2011) Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. Mol Cell Biol 31(11):2326–2340
Sarajarvi T, Marttinen M, Natunen T, Kauppinen T, Makinen P, Helisalmi S et al (2015) Genetic variation in delta-opioid receptor associates with increased beta- and gamma-secretase activity in the late stages of Alzheimer’s disease. J Alzheimers Dis 48(2):507–516
Teng L, Zhao J, Wang F, Ma L, Pei G (2010) A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis. Cell Res 20(2):138–153
Wang K, Zhang H, Bloss CS, Duvvuri V, Kaye W, Schork NJ et al (2011) A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. Mol Psychiatry 16(9):949–959
Xu K, Liu XH, Nagarajan S, Gu XY, Goldman D (2002) Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. Am J Med Genet 110(1):45–50
Xuei X, Flury-Wetherill L, Bierut L, Dick D, Nurnberger J Jr, Foroud T et al (2007) The opioid system in alcohol and drug dependence: family-based association study. Am J Med Genet B Neuropsychiatr Genet 144B(7):877–884
Yoo JH, Kitchen I, Bailey A (2012) The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us? Br J Pharmacol 166(7):1993–2014
Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J (2008) The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13(5):531–543
Zhang H, Gelernter J, Gruen JR, Kranzler HR, Herman AI, Simen AA (2010) Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region. J Hum Genet 55(5):278–284
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Crist, R.C., Clarke, TK. (2016). OPRD1 Genetic Variation and Human Disease. In: Jutkiewicz, E. (eds) Delta Opioid Receptor Pharmacology and Therapeutic Applications. Handbook of Experimental Pharmacology, vol 247. Springer, Cham. https://doi.org/10.1007/164_2016_112
Download citation
DOI: https://doi.org/10.1007/164_2016_112
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95131-7
Online ISBN: 978-3-319-95133-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)